J&J: 10 new drugs by 2019, each with $1B potential

Johnson & Johnson on Wednesday said it expects 10 new drugs to be launched by 2019, each with the potential to exceed $1 billion in revenue.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.